Skip to main content

Carrera Capital Advisors

Position in GILD — Gilead Sciences, Inc.

CIK 2035329 TROY, MI

Position in GILD

as of Mar 31, 2026 · filed May 4, 2026
Position Value
$209,751
-$3,677,935 QoQ
Shares Held
1,505
-95.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Carrera Capital Advisors holds $6,568,870 across 3 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $209,751 1,505
2025-03-31 $3,887,686 34,696
2024-12-31 $3,085,158 33,400
2024-09-30 $2,141,776 25,546
2024-06-30 $1,417,482 20,660